Global Veterinary Therapeutics Market Growth (Status and Outlook) 2023-2029

March 2023 | 100 pages | ID: GE67AA30852CEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

LPI (LP Information)' newest research report, the “Veterinary Therapeutics Industry Forecast” looks at past sales and reviews total world Veterinary Therapeutics sales in 2022, providing a comprehensive analysis by region and market sector of projected Veterinary Therapeutics sales for 2023 through 2029. With Veterinary Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Therapeutics industry.

This Insight Report provides a comprehensive analysis of the global Veterinary Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Veterinary Therapeutics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Therapeutics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Therapeutics.

The global Veterinary Therapeutics market size is projected to grow from US$ 29410 million in 2022 to US$ 38550 million in 2029; it is expected to grow at a CAGR of 3.9% from 2023 to 2029.

United States market for Veterinary Therapeutics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Veterinary Therapeutics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Veterinary Therapeutics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Veterinary Therapeutics players cover Bayer AG, Boehringer Ingelheim GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Eli Lilly and Company (Elanco Animal Health), Merck Animal Health, Sanofi (Merial Animal Health), Virbac and Vetoquinol S.A., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Therapeutics market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

• Anti-inflammatory
• Parasiticides
• Others

Segmentation by application

• Hospitals
• Veterinary Clinics
• Drug Stores
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Bayer AG
• Boehringer Ingelheim GmbH
• Ceva Sante Animale
• Dechra Pharmaceuticals PLC
• Eli Lilly and Company (Elanco Animal Health)
• Merck Animal Health
• Sanofi (Merial Animal Health)
• Virbac
• Vetoquinol S.A.
• Zoetis, Inc.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Veterinary Therapeutics Market Size 2018-2029
  2.1.2 Veterinary Therapeutics Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Veterinary Therapeutics Segment by Type
  2.2.1 Anti-inflammatory
  2.2.2 Parasiticides
  2.2.3 Others
2.3 Veterinary Therapeutics Market Size by Type
  2.3.1 Veterinary Therapeutics Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Veterinary Therapeutics Market Size Market Share by Type (2018-2023)
2.4 Veterinary Therapeutics Segment by Application
  2.4.1 Hospitals
  2.4.2 Veterinary Clinics
  2.4.3 Drug Stores
  2.4.4 Others
2.5 Veterinary Therapeutics Market Size by Application
  2.5.1 Veterinary Therapeutics Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Veterinary Therapeutics Market Size Market Share by Application (2018-2023)

3 VETERINARY THERAPEUTICS MARKET SIZE BY PLAYER

3.1 Veterinary Therapeutics Market Size Market Share by Players
  3.1.1 Global Veterinary Therapeutics Revenue by Players (2018-2023)
  3.1.2 Global Veterinary Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Veterinary Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 VETERINARY THERAPEUTICS BY REGIONS

4.1 Veterinary Therapeutics Market Size by Regions (2018-2023)
4.2 Americas Veterinary Therapeutics Market Size Growth (2018-2023)
4.3 APAC Veterinary Therapeutics Market Size Growth (2018-2023)
4.4 Europe Veterinary Therapeutics Market Size Growth (2018-2023)
4.5 Middle East & Africa Veterinary Therapeutics Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Veterinary Therapeutics Market Size by Country (2018-2023)
5.2 Americas Veterinary Therapeutics Market Size by Type (2018-2023)
5.3 Americas Veterinary Therapeutics Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Veterinary Therapeutics Market Size by Region (2018-2023)
6.2 APAC Veterinary Therapeutics Market Size by Type (2018-2023)
6.3 APAC Veterinary Therapeutics Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Veterinary Therapeutics by Country (2018-2023)
7.2 Europe Veterinary Therapeutics Market Size by Type (2018-2023)
7.3 Europe Veterinary Therapeutics Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Veterinary Therapeutics by Region (2018-2023)
8.2 Middle East & Africa Veterinary Therapeutics Market Size by Type (2018-2023)
8.3 Middle East & Africa Veterinary Therapeutics Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL VETERINARY THERAPEUTICS MARKET FORECAST

10.1 Global Veterinary Therapeutics Forecast by Regions (2024-2029)
  10.1.1 Global Veterinary Therapeutics Forecast by Regions (2024-2029)
  10.1.2 Americas Veterinary Therapeutics Forecast
  10.1.3 APAC Veterinary Therapeutics Forecast
  10.1.4 Europe Veterinary Therapeutics Forecast
  10.1.5 Middle East & Africa Veterinary Therapeutics Forecast
10.2 Americas Veterinary Therapeutics Forecast by Country (2024-2029)
  10.2.1 United States Veterinary Therapeutics Market Forecast
  10.2.2 Canada Veterinary Therapeutics Market Forecast
  10.2.3 Mexico Veterinary Therapeutics Market Forecast
  10.2.4 Brazil Veterinary Therapeutics Market Forecast
10.3 APAC Veterinary Therapeutics Forecast by Region (2024-2029)
  10.3.1 China Veterinary Therapeutics Market Forecast
  10.3.2 Japan Veterinary Therapeutics Market Forecast
  10.3.3 Korea Veterinary Therapeutics Market Forecast
  10.3.4 Southeast Asia Veterinary Therapeutics Market Forecast
  10.3.5 India Veterinary Therapeutics Market Forecast
  10.3.6 Australia Veterinary Therapeutics Market Forecast
10.4 Europe Veterinary Therapeutics Forecast by Country (2024-2029)
  10.4.1 Germany Veterinary Therapeutics Market Forecast
  10.4.2 France Veterinary Therapeutics Market Forecast
  10.4.3 UK Veterinary Therapeutics Market Forecast
  10.4.4 Italy Veterinary Therapeutics Market Forecast
  10.4.5 Russia Veterinary Therapeutics Market Forecast
10.5 Middle East & Africa Veterinary Therapeutics Forecast by Region (2024-2029)
  10.5.1 Egypt Veterinary Therapeutics Market Forecast
  10.5.2 South Africa Veterinary Therapeutics Market Forecast
  10.5.3 Israel Veterinary Therapeutics Market Forecast
  10.5.4 Turkey Veterinary Therapeutics Market Forecast
  10.5.5 GCC Countries Veterinary Therapeutics Market Forecast
10.6 Global Veterinary Therapeutics Forecast by Type (2024-2029)
10.7 Global Veterinary Therapeutics Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Bayer AG
  11.1.1 Bayer AG Company Information
  11.1.2 Bayer AG Veterinary Therapeutics Product Offered
  11.1.3 Bayer AG Veterinary Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Bayer AG Main Business Overview
  11.1.5 Bayer AG Latest Developments
11.2 Boehringer Ingelheim GmbH
  11.2.1 Boehringer Ingelheim GmbH Company Information
  11.2.2 Boehringer Ingelheim GmbH Veterinary Therapeutics Product Offered
  11.2.3 Boehringer Ingelheim GmbH Veterinary Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Boehringer Ingelheim GmbH Main Business Overview
  11.2.5 Boehringer Ingelheim GmbH Latest Developments
11.3 Ceva Sante Animale
  11.3.1 Ceva Sante Animale Company Information
  11.3.2 Ceva Sante Animale Veterinary Therapeutics Product Offered
  11.3.3 Ceva Sante Animale Veterinary Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Ceva Sante Animale Main Business Overview
  11.3.5 Ceva Sante Animale Latest Developments
11.4 Dechra Pharmaceuticals PLC
  11.4.1 Dechra Pharmaceuticals PLC Company Information
  11.4.2 Dechra Pharmaceuticals PLC Veterinary Therapeutics Product Offered
  11.4.3 Dechra Pharmaceuticals PLC Veterinary Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 Dechra Pharmaceuticals PLC Main Business Overview
  11.4.5 Dechra Pharmaceuticals PLC Latest Developments
11.5 Eli Lilly and Company (Elanco Animal Health)
  11.5.1 Eli Lilly and Company (Elanco Animal Health) Company Information
  11.5.2 Eli Lilly and Company (Elanco Animal Health) Veterinary Therapeutics Product Offered
  11.5.3 Eli Lilly and Company (Elanco Animal Health) Veterinary Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 Eli Lilly and Company (Elanco Animal Health) Main Business Overview
  11.5.5 Eli Lilly and Company (Elanco Animal Health) Latest Developments
11.6 Merck Animal Health
  11.6.1 Merck Animal Health Company Information
  11.6.2 Merck Animal Health Veterinary Therapeutics Product Offered
  11.6.3 Merck Animal Health Veterinary Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 Merck Animal Health Main Business Overview
  11.6.5 Merck Animal Health Latest Developments
11.7 Sanofi (Merial Animal Health)
  11.7.1 Sanofi (Merial Animal Health) Company Information
  11.7.2 Sanofi (Merial Animal Health) Veterinary Therapeutics Product Offered
  11.7.3 Sanofi (Merial Animal Health) Veterinary Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
  11.7.4 Sanofi (Merial Animal Health) Main Business Overview
  11.7.5 Sanofi (Merial Animal Health) Latest Developments
11.8 Virbac
  11.8.1 Virbac Company Information
  11.8.2 Virbac Veterinary Therapeutics Product Offered
  11.8.3 Virbac Veterinary Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
  11.8.4 Virbac Main Business Overview
  11.8.5 Virbac Latest Developments
11.9 Vetoquinol S.A.
  11.9.1 Vetoquinol S.A. Company Information
  11.9.2 Vetoquinol S.A. Veterinary Therapeutics Product Offered
  11.9.3 Vetoquinol S.A. Veterinary Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
  11.9.4 Vetoquinol S.A. Main Business Overview
  11.9.5 Vetoquinol S.A. Latest Developments
11.10 Zoetis, Inc.
  11.10.1 Zoetis, Inc. Company Information
  11.10.2 Zoetis, Inc. Veterinary Therapeutics Product Offered
  11.10.3 Zoetis, Inc. Veterinary Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
  11.10.4 Zoetis, Inc. Main Business Overview
  11.10.5 Zoetis, Inc. Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Veterinary Therapeutics Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Anti-inflammatory
Table 3. Major Players of Parasiticides
Table 4. Major Players of Others
Table 5. Veterinary Therapeutics Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Veterinary Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Veterinary Therapeutics Market Size Market Share by Type (2018-2023)
Table 8. Veterinary Therapeutics Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Veterinary Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Veterinary Therapeutics Market Size Market Share by Application (2018-2023)
Table 11. Global Veterinary Therapeutics Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Veterinary Therapeutics Revenue Market Share by Player (2018-2023)
Table 13. Veterinary Therapeutics Key Players Head office and Products Offered
Table 14. Veterinary Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Veterinary Therapeutics Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Veterinary Therapeutics Market Size Market Share by Regions (2018-2023)
Table 19. Global Veterinary Therapeutics Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Veterinary Therapeutics Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Veterinary Therapeutics Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Veterinary Therapeutics Market Size Market Share by Country (2018-2023)
Table 23. Americas Veterinary Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Veterinary Therapeutics Market Size Market Share by Type (2018-2023)
Table 25. Americas Veterinary Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Veterinary Therapeutics Market Size Market Share by Application (2018-2023)
Table 27. APAC Veterinary Therapeutics Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Veterinary Therapeutics Market Size Market Share by Region (2018-2023)
Table 29. APAC Veterinary Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Veterinary Therapeutics Market Size Market Share by Type (2018-2023)
Table 31. APAC Veterinary Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Veterinary Therapeutics Market Size Market Share by Application (2018-2023)
Table 33. Europe Veterinary Therapeutics Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Veterinary Therapeutics Market Size Market Share by Country (2018-2023)
Table 35. Europe Veterinary Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Veterinary Therapeutics Market Size Market Share by Type (2018-2023)
Table 37. Europe Veterinary Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Veterinary Therapeutics Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Veterinary Therapeutics Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Veterinary Therapeutics Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Veterinary Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Veterinary Therapeutics Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Veterinary Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Veterinary Therapeutics Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Veterinary Therapeutics
Table 46. Key Market Challenges & Risks of Veterinary Therapeutics
Table 47. Key Industry Trends of Veterinary Therapeutics
Table 48. Global Veterinary Therapeutics Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Veterinary Therapeutics Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Veterinary Therapeutics Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Veterinary Therapeutics Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Bayer AG Details, Company Type, Veterinary Therapeutics Area Served and Its Competitors
Table 53. Bayer AG Veterinary Therapeutics Product Offered
Table 54. Bayer AG Veterinary Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Bayer AG Main Business
Table 56. Bayer AG Latest Developments
Table 57. Boehringer Ingelheim GmbH Details, Company Type, Veterinary Therapeutics Area Served and Its Competitors
Table 58. Boehringer Ingelheim GmbH Veterinary Therapeutics Product Offered
Table 59. Boehringer Ingelheim GmbH Main Business
Table 60. Boehringer Ingelheim GmbH Veterinary Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Boehringer Ingelheim GmbH Latest Developments
Table 62. Ceva Sante Animale Details, Company Type, Veterinary Therapeutics Area Served and Its Competitors
Table 63. Ceva Sante Animale Veterinary Therapeutics Product Offered
Table 64. Ceva Sante Animale Main Business
Table 65. Ceva Sante Animale Veterinary Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Ceva Sante Animale Latest Developments
Table 67. Dechra Pharmaceuticals PLC Details, Company Type, Veterinary Therapeutics Area Served and Its Competitors
Table 68. Dechra Pharmaceuticals PLC Veterinary Therapeutics Product Offered
Table 69. Dechra Pharmaceuticals PLC Main Business
Table 70. Dechra Pharmaceuticals PLC Veterinary Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Dechra Pharmaceuticals PLC Latest Developments
Table 72. Eli Lilly and Company (Elanco Animal Health) Details, Company Type, Veterinary Therapeutics Area Served and Its Competitors
Table 73. Eli Lilly and Company (Elanco Animal Health) Veterinary Therapeutics Product Offered
Table 74. Eli Lilly and Company (Elanco Animal Health) Main Business
Table 75. Eli Lilly and Company (Elanco Animal Health) Veterinary Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Eli Lilly and Company (Elanco Animal Health) Latest Developments
Table 77. Merck Animal Health Details, Company Type, Veterinary Therapeutics Area Served and Its Competitors
Table 78. Merck Animal Health Veterinary Therapeutics Product Offered
Table 79. Merck Animal Health Main Business
Table 80. Merck Animal Health Veterinary Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Merck Animal Health Latest Developments
Table 82. Sanofi (Merial Animal Health) Details, Company Type, Veterinary Therapeutics Area Served and Its Competitors
Table 83. Sanofi (Merial Animal Health) Veterinary Therapeutics Product Offered
Table 84. Sanofi (Merial Animal Health) Main Business
Table 85. Sanofi (Merial Animal Health) Veterinary Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Sanofi (Merial Animal Health) Latest Developments
Table 87. Virbac Details, Company Type, Veterinary Therapeutics Area Served and Its Competitors
Table 88. Virbac Veterinary Therapeutics Product Offered
Table 89. Virbac Main Business
Table 90. Virbac Veterinary Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Virbac Latest Developments
Table 92. Vetoquinol S.A. Details, Company Type, Veterinary Therapeutics Area Served and Its Competitors
Table 93. Vetoquinol S.A. Veterinary Therapeutics Product Offered
Table 94. Vetoquinol S.A. Main Business
Table 95. Vetoquinol S.A. Veterinary Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Vetoquinol S.A. Latest Developments
Table 97. Zoetis, Inc. Details, Company Type, Veterinary Therapeutics Area Served and Its Competitors
Table 98. Zoetis, Inc. Veterinary Therapeutics Product Offered
Table 99. Zoetis, Inc. Main Business
Table 100. Zoetis, Inc. Veterinary Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Zoetis, Inc. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Veterinary Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Veterinary Therapeutics Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Veterinary Therapeutics Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Veterinary Therapeutics Sales Market Share by Country/Region (2022)
Figure 8. Veterinary Therapeutics Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Veterinary Therapeutics Market Size Market Share by Type in 2022
Figure 10. Veterinary Therapeutics in Hospitals
Figure 11. Global Veterinary Therapeutics Market: Hospitals (2018-2023) & ($ Millions)
Figure 12. Veterinary Therapeutics in Veterinary Clinics
Figure 13. Global Veterinary Therapeutics Market: Veterinary Clinics (2018-2023) & ($ Millions)
Figure 14. Veterinary Therapeutics in Drug Stores
Figure 15. Global Veterinary Therapeutics Market: Drug Stores (2018-2023) & ($ Millions)
Figure 16. Veterinary Therapeutics in Others
Figure 17. Global Veterinary Therapeutics Market: Others (2018-2023) & ($ Millions)
Figure 18. Global Veterinary Therapeutics Market Size Market Share by Application in 2022
Figure 19. Global Veterinary Therapeutics Revenue Market Share by Player in 2022
Figure 20. Global Veterinary Therapeutics Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Veterinary Therapeutics Market Size 2018-2023 ($ Millions)
Figure 22. APAC Veterinary Therapeutics Market Size 2018-2023 ($ Millions)
Figure 23. Europe Veterinary Therapeutics Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Veterinary Therapeutics Market Size 2018-2023 ($ Millions)
Figure 25. Americas Veterinary Therapeutics Value Market Share by Country in 2022
Figure 26. United States Veterinary Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Veterinary Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Veterinary Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Veterinary Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Veterinary Therapeutics Market Size Market Share by Region in 2022
Figure 31. APAC Veterinary Therapeutics Market Size Market Share by Type in 2022
Figure 32. APAC Veterinary Therapeutics Market Size Market Share by Application in 2022
Figure 33. China Veterinary Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Veterinary Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Veterinary Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Veterinary Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Veterinary Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Veterinary Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Veterinary Therapeutics Market Size Market Share by Country in 2022
Figure 40. Europe Veterinary Therapeutics Market Size Market Share by Type (2018-2023)
Figure 41. Europe Veterinary Therapeutics Market Size Market Share by Application (2018-2023)
Figure 42. Germany Veterinary Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Veterinary Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Veterinary Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Veterinary Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Veterinary Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Veterinary Therapeutics Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Veterinary Therapeutics Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Veterinary Therapeutics Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Veterinary Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Veterinary Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Veterinary Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Veterinary Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Veterinary Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Veterinary Therapeutics Market Size 2024-2029 ($ Millions)
Figure 56. APAC Veterinary Therapeutics Market Size 2024-2029 ($ Millions)
Figure 57. Europe Veterinary Therapeutics Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Veterinary Therapeutics Market Size 2024-2029 ($ Millions)
Figure 59. United States Veterinary Therapeutics Market Size 2024-2029 ($ Millions)
Figure 60. Canada Veterinary Therapeutics Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Veterinary Therapeutics Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Veterinary Therapeutics Market Size 2024-2029 ($ Millions)
Figure 63. China Veterinary Therapeutics Market Size 2024-2029 ($ Millions)
Figure 64. Japan Veterinary Therapeutics Market Size 2024-2029 ($ Millions)
Figure 65. Korea Veterinary Therapeutics Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Veterinary Therapeutics Market Size 2024-2029 ($ Millions)
Figure 67. India Veterinary Therapeutics Market Size 2024-2029 ($ Millions)
Figure 68. Australia Veterinary Therapeutics Market Size 2024-2029 ($ Millions)
Figure 69. Germany Veterinary Therapeutics Market Size 2024-2029 ($ Millions)
Figure 70. France Veterinary Therapeutics Market Size 2024-2029 ($ Millions)
Figure 71. UK Veterinary Therapeutics Market Size 2024-2029 ($ Millions)
Figure 72. Italy Veterinary Therapeutics Market Size 2024-2029 ($ Millions)
Figure 73. Russia Veterinary Therapeutics Market Size 2024-2029 ($ Millions)
Figure 74. Spain Veterinary Therapeutics Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Veterinary Therapeutics Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Veterinary Therapeutics Market Size 2024-2029 ($ Millions)
Figure 77. Israel Veterinary Therapeutics Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Veterinary Therapeutics Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Veterinary Therapeutics Market Size 2024-2029 ($ Millions)
Figure 80. Global Veterinary Therapeutics Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Veterinary Therapeutics Market Size Market Share Forecast by Application (2024-2029)